Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

CRH causes hair loss by reducing cell survival in hair follicles.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.